Market Value1,317,585,000
Total Holdings61
File Date2022-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NXTC / NextCure, Inc.
ICPT / Intercept Pharmaceuticals Inc Call
ALGN / Align Technology, Inc.
XNCR / Xencor, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
BOLT / Bolt Biotherapeutics, Inc.
GERN / Geron Corporation Call
INSM / Insmed Incorporated
CCXI / Churchill Capital Corp XI
CCXI / Churchill Capital Corp XI Call
QURE / uniQure N.V.
CLDX / Celldex Therapeutics, Inc.
JNCE / Jounce Therapeutics Inc
INKT / MiNK Therapeutics, Inc.
CYT / Cyteir Therapeutics, Inc.
14161H108 / Cardtronics PLC
ALGS / Aligos Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
ZYME / Zymeworks Inc.
RHHBY / Roche Holding AG - Depositary Receipt (Common Stock)
SRPT / Sarepta Therapeutics, Inc.
EW / Edwards Lifesciences Corporation
VIR / Vir Biotechnology, Inc. Put
PTGX / Protagonist Therapeutics, Inc.
PTGX / Protagonist Therapeutics, Inc. Call
BPMC / Blueprint Medicines Corporation
PDSB / PDS Biotechnology Corporation
INBX.V / Inhibrx, Inc.
IRTC / iRhythm Holdings, Inc.
KURA / Kura Oncology, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
IFRX / InflaRx N.V.
PFE / Pfizer Inc.
DXCM / DexCom, Inc.
XBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF Put
SNDX / Syndax Pharmaceuticals, Inc.
AKUS / Akouos Inc
IMGN / ImmunoGen, Inc.
ZTS / Zoetis Inc.
RGNX / REGENXBIO Inc.
TVTX / Travere Therapeutics, Inc.
NTRA / Natera, Inc.
CMPI / Checkmate Pharmaceuticals Inc
NVCR / NovoCure Limited Call
CINC / CinCor Pharma Inc
GH / Guardant Health, Inc.
ITCI / Intra-Cellular Therapies, Inc.
SRRA / Sierra Oncology Inc
HRTX / Heron Therapeutics, Inc.
OBSV / ObsEva SA.
CYTK / Cytokinetics, Incorporated
HZNP / Horizon Therapeutics Plc
ISEE / IVERIC bio Inc
AXSM / Axsome Therapeutics, Inc. Put
UTHR / United Therapeutics Corporation
PTCT / PTC Therapeutics, Inc.
ACET / Adicet Bio, Inc.
GERN / Geron Corporation
RETA / Reata Pharmaceuticals Inc - Class A
SYBX / Synlogic, Inc.
FULC / Fulcrum Therapeutics, Inc.
PODD / Insulet Corporation
KURA / Kura Oncology, Inc. Call
CTIC / CTI BioPharma Corp
INZY / Inozyme Pharma, Inc.
ABBV / AbbVie Inc.
BMRN / BioMarin Pharmaceutical Inc.
KRTX / Karuna Therapeutics, Inc.
NCNA / NuCana plc - Depositary Receipt (Common Stock)
GRTX / Galera Therapeutics, Inc.
ASND / Ascendis Pharma A/S
FUSN / Fusion Pharmaceuticals Inc.
VRTX / Vertex Pharmaceuticals Incorporated
YMAB / Y-mAbs Therapeutics, Inc.
AVTE / Aerovate Therapeutics, Inc.
IWM / iShares Trust - iShares Russell 2000 ETF Put
SPY / State Street SPDR S&P 500 ETF Trust Put
QQQ / Invesco QQQ Trust, Series 1 Put
AGEN / Agenus Inc.
IMTX / Immatics N.V.
VERA / Vera Therapeutics, Inc.
MRNS / Marinus Pharmaceuticals, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.